- Home
- TBNK vs FBRX Comparison
TBNK vs FBRX Comparison
Compare TBNK & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBNK
- FBRX
- Stock Information
- Founded
- TBNK 1921
- FBRX N/A
- Country
- TBNK United States
- FBRX United States
- Employees
- TBNK N/A
- FBRX N/A
- Industry
- TBNK Savings Institutions
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- TBNK Finance
- FBRX Health Care
- Exchange
- TBNK Nasdaq
- FBRX Nasdaq
- Market Cap
- TBNK 70.9M
- FBRX 76.1M
- IPO Year
- TBNK N/A
- FBRX N/A
- Fundamental
- Price
- TBNK $8.28
- FBRX $10.98
- Analyst Decision
- TBNK Hold
- FBRX Strong Buy
- Analyst Count
- TBNK 2
- FBRX 4
- Target Price
- TBNK $9.89
- FBRX $77.58
- AVG Volume (30 Days)
- TBNK 7.5K
- FBRX 27.5K
- Earning Date
- TBNK 01-31-2025
- FBRX 03-17-2025
- Dividend Yield
- TBNK 0.48%
- FBRX N/A
- EPS Growth
- TBNK N/A
- FBRX N/A
- EPS
- TBNK N/A
- FBRX N/A
- Revenue
- TBNK $36,403,000.00
- FBRX N/A
- Revenue This Year
- TBNK N/A
- FBRX N/A
- Revenue Next Year
- TBNK $14.93
- FBRX N/A
- P/E Ratio
- TBNK N/A
- FBRX N/A
- Revenue Growth
- TBNK N/A
- FBRX N/A
- 52 Week Low
- TBNK $6.92
- FBRX $4.11
- 52 Week High
- TBNK $11.44
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- TBNK 32.63
- FBRX 36.53
- Support Level
- TBNK $8.61
- FBRX $9.81
- Resistance Level
- TBNK $8.87
- FBRX $13.13
- Average True Range (ATR)
- TBNK 0.18
- FBRX 1.52
- MACD
- TBNK -0.02
- FBRX -0.08
- Stochastic Oscillator
- TBNK 0.00
- FBRX 18.17
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).